Susan Galbraith, Executive Vice President in Oncology R&D at AstraZeneca, shared a post on LinkedIn:
“Every person impacted by cancer has a unique story, and it is these patient stories that inspire and motivate us at AstraZeneca to continue to push the boundaries of science to deliver life changing medicines.
For me, like many others, I have lost too many loved ones to cancer and the opportunity to improve outcomes for future patients is a key driver for me every day.
At our recent Patient Advocacy Leaders Summit, we asked advocates to share what drives their commitment to eliminate cancer as a cause of death and, as you can see from the video, their responses are both personal and optimistic.”
Other articles featuring Susan Galbraith on OncoDaily.